Premium
P2‐069: INTRANASAL DANTROLENE AS A DISEASE‐MODIFYING DRUG IN ALZHEIMER 5XFAD MICE
Author(s) -
Shi Yun,
Zhang Lei,
Gao Xue,
Zhang Jing,
Ben-Abou Matan,
Meng Qingcheng,
Hepner Adrian,
Eckenhoff Maryellen F.,
Wei Huafeng
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - Norwegian
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.2476
Subject(s) - medicine , nasal administration , dantrolene , subcutaneous injection , neurology , pharmacology , anesthesia , psychiatry , calcium
Craig W. Lindsley, Jeffrey Conn, Carrie K. Jones, Vanderbilt University, Nashville, TN, USA; Vanderbilt Center for Neuroscience Drug Discovery, Nashville, TN, USA; Wake Forest Health Sciences, Winston-Salem, NC, USA; Vanderbilt University Medical Center, Nashville, TN, USA; Psychiatry, Center for Cognitive Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Contact e-mail: jason.k. russell@vanderbilt.edu